A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

This transcript has been edited for clarity. Kathy D. Miller, MD: Hi. I'm Kathy Miller, Professor of Medicine at the IU School of Medicine and Joining me today is Dr Richard Zellars, the Chair of the ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...